These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37111714)

  • 1. Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits.
    Rezaeian Shiadeh SN; Hadizadeh F; Khodaverdi E; Gorji Valokola M; Rakhshani S; Kamali H; Nokhodchi A
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro, ex-vivo, and in-vivo evaluation of buprenorphine HCl release from an in situ forming gel of PLGA-PEG-PLGA using N‑methyl‑2‑pyrrolidone as solvent.
    Kamali H; Khodaverdi E; Hadizadeh F; Mohajeri SA
    Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():561-575. PubMed ID: 30606566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-liquid crystals for 2 months controlled risperidone release: In-vitro evaluation and pharmacokinetics in rabbits.
    Shiadeh SNR; Khodaverdi E; Maleki MF; Eisvand F; Boujaran H; Zarei H; Vosooghi R; Hadizadeh F; Kamali H
    Int J Pharm; 2022 Apr; 618():121649. PubMed ID: 35278600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ forming risperidone implants: Effect of PLGA attributes on product performance.
    Wang X; Bao Q; Wang R; Kwok O; Maurus K; Wang Y; Qin B; Burgess DJ
    J Control Release; 2023 Sep; 361():777-791. PubMed ID: 37591464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].
    Lin X; Tang X; Xu YH; Zhang Y; Zhang Y; He HB
    Yao Xue Xue Bao; 2015 Jun; 50(6):775-82. PubMed ID: 26521452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants.
    Liu Q; Zhang H; Zhou G; Xie S; Zou H; Yu Y; Li G; Sun D; Zhang G; Lu Y; Zhong Y
    Int J Pharm; 2010 Sep; 397(1-2):122-9. PubMed ID: 20650309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impacts of PLGA/PEG Triblock Copolymers with Variable Molecular Weights on the Sustained Release of Buprenorphine.
    Kamali H; Khodaverdi E; Mohammadpour F; Kakavand A; Shiadeh SNR; Oroojalian F; Hadizadeh F
    Curr Drug Deliv; 2022; 19(3):357-368. PubMed ID: 34238190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and
    Movaffagh J; Hadizadeh F; Khodaverdi E; Khalili B; Rezaeian Shiadeh SN; Kamali H; Oroojalian F
    Iran J Basic Med Sci; 2022 Mar; 25(3):341-351. PubMed ID: 35656181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-situ forming biodegradable implants for sustained Fluocinolone acetonide release to the posterior eye: In-vitro and in-vivo investigations in rabbits.
    Karimi M; Abrishami M; Farzadnia M; Kamali H; Malaekeh-Nikouei B
    Int J Pharm; 2024 Apr; 654():123973. PubMed ID: 38458402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
    Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
    Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems.
    Patel RB; Carlson AN; Solorio L; Exner AA
    J Biomed Mater Res A; 2010 Aug; 94(2):476-84. PubMed ID: 20186771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel adapter method for in vitro release testing of in situ forming implants.
    Wang X; Bao Q; Suh MS; Kastellorizios M; Wang R; Burgess DJ
    Int J Pharm; 2022 Jun; 621():121777. PubMed ID: 35489601
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Khodaverdi E; Delroba K; Mohammadpour F; Khameneh B; Sajadi Tabassi SA; Tafaghodi M; Kamali H; Hadizadeh F
    Curr Drug Deliv; 2020; 17(2):174-183. PubMed ID: 31987020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo.
    Lin X; Yang S; Gou J; Zhao M; Zhang Y; Qi N; He H; Cai C; Tang X; Guo P
    J Mater Sci Mater Med; 2012 Feb; 23(2):443-55. PubMed ID: 22170300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
    Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
    Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.
    Solorio L; Olear AM; Hamilton JI; Patel RB; Beiswenger AC; Wallace JE; Zhou H; Exner AA
    Theranostics; 2012; 2(11):1064-77. PubMed ID: 23227123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond Q1/Q2: The Impact of Manufacturing Conditions and Test Methods on Drug Release From PLGA-Based Microparticle Depot Formulations.
    Garner J; Skidmore S; Park H; Park K; Choi S; Wang Y
    J Pharm Sci; 2018 Jan; 107(1):353-361. PubMed ID: 29107048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro-in vivo correlation of parenteral PLGA microspheres: Effect of variable burst release.
    Andhariya JV; Jog R; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ
    J Control Release; 2019 Nov; 314():25-37. PubMed ID: 31654687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.